Wenqin Feng, Ph.D. - Publications

Affiliations: 
2001 Pennsylvania State University, State College, PA, United States 
Area:
Cell Biology, Molecular Biology

3/16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2004 Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J, Dreyfuss G. eIF4A3 is a novel component of the exon junction complex. Rna (New York, N.Y.). 10: 200-9. PMID 14730019 DOI: 10.1261/Rna.5230104  0.331
2002 Feng W, Hopper AK. A Los1p-independent pathway for nuclear export of intronless tRNAs in Saccharomycescerevisiae. Proceedings of the National Academy of Sciences of the United States of America. 99: 5412-7. PMID 11959996 DOI: 10.1073/Pnas.082682699  0.353
1999 Feng W, Benko AL, Lee JH, Stanford DR, Hopper AK. Antagonistic effects of NES and NLS motifs determine S. cerevisiae Rna1p subcellular distribution. Journal of Cell Science. 112: 339-47. PMID 9885287  0.403
Low-probability matches (unlikely to be authored by this person)
2004 Gubitz AK, Feng W, Dreyfuss G. The SMN complex. Experimental Cell Research. 296: 51-6. PMID 15120993 DOI: 10.1016/J.Yexcr.2004.03.022  0.273
2005 Golembe TJ, Yong J, Battle DJ, Feng W, Wan L, Dreyfuss G. Lymphotropic Herpesvirus saimiri uses the SMN complex to assemble Sm cores on its small RNAs. Molecular and Cellular Biology. 25: 602-11. PMID 15632062 DOI: 10.1128/Mcb.25.2.602-611.2005  0.244
2005 Feng W, Gubitz AK, Wan L, Battle DJ, Dostie J, Golembe TJ, Dreyfuss G. Gemins modulate the expression and activity of the SMN complex. Human Molecular Genetics. 14: 1605-11. PMID 15843395 DOI: 10.1093/Hmg/Ddi168  0.164
2001 Vollrath D, Feng W, Duncan JL, Yasumura D, D'Cruz PM, Chappelow A, Matthes MT, Kay MA, LaVail MM. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proceedings of the National Academy of Sciences of the United States of America. 98: 12584-9. PMID 11592982 DOI: 10.1073/Pnas.221364198  0.137
2023 Goto K, Goto Y, Kubo T, Ninomiya K, Kim SW, Planchard D, Ahn MJ, Smit EF, de Langen AJ, Pérol M, Pons-Tostivint E, Novello S, Hayashi H, Shimizu J, Kim DW, ... ... Feng W, et al. Trastuzumab Deruxtecan in Patients With -Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301361. PMID 37694347 DOI: 10.1200/JCO.23.01361  0.112
2022 Feng W, Lin A, Sun L, Wei T, Ying H, Zhang J, Luo P, Zhu W. Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma. Cancer Cell International. 22: 186. PMID 35562800 DOI: 10.1186/s12935-022-02604-z  0.101
2017 Kristof J, Sakrison K, Jin X, Nakamaru K, Schneider M, Beckman RA, Freeman D, Spittle C, Feng W. Real-Time Reverse-Transcription Quantitative Polymerase Chain Reaction Assay Is a Feasible Method for the Relative Quantification of Heregulin Expression in Non-Small Cell Lung Cancer Tissue. Biomarker Insights. 12: 1177271917699850. PMID 28469400 DOI: 10.1177/1177271917699850  0.075
2023 Garrido C, Manoogian M, Ghambire D, Lucas S, Karnoub M, Olson MT, Hicks DG, Tozbikian G, Prat A, Ueno NT, Modi S, Feng W, Pugh J, Hsu C, Tsurutani J, et al. Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer. Virchows Archiv : An International Journal of Pathology. PMID 37857998 DOI: 10.1007/s00428-023-03671-x  0.067
2015 Mendell J, Freeman DJ, Feng W, Hettmann T, Schneider M, Blum S, Ruhe J, Bange J, Nakamaru K, Chen S, Tsuchihashi Z, von Pawel J, Copigneaux C, Beckman RA. Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer. Ebiomedicine. 2: 264-71. PMID 26137564 DOI: 10.1016/j.ebiom.2015.02.005  0.064
2023 Feng W, Inoue R, Kuwata T, Niikura N, Fujii S, Kumaki N, Honda K, Xu LA, Goetz A, Gaule P, Cogswell J, Rimm DL, McGee R. Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 37093713 DOI: 10.1097/PAI.0000000000001126  0.061
2024 Smit EF, Felip E, Uprety D, Nagasaka M, Nakagawa K, Paz-Ares Rodríguez L, Pacheco JM, Li BT, Planchard D, Baik C, Goto Y, Murakami H, Saltos A, Pereira K, Taguchi A, ... ... Feng W, et al. Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial. The Lancet. Oncology. 25: 439-454. PMID 38547891 DOI: 10.1016/S1470-2045(24)00064-0  0.058
2015 Zahir H, Brown KS, Vandell AG, Desai M, Maa JF, Dishy V, Lomeli B, Feussner A, Feng W, He L, Grosso MA, Lanz HJ, Antman EM. Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate Circulation. 131: 82-90. PMID 25403645 DOI: 10.1161/CIRCULATIONAHA.114.013445  0.052
2020 Chu K, Bu X, Sun Z, Wang Y, Feng W, Xiao L, Jiang F, Tang X. Feasibility of a Nurse-Trained, Family Member-Delivered Rehabilitation Model for Disabled Stroke Patients in Rural Chongqing, China. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 29: 105382. PMID 33096497 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105382  0.019
Hide low-probability matches.